European Pharmacopoeia Commission Adopts New and Revised Texts
The commission adopts 24 new and 72 revised texts for inclusion in the European Pharmacopoeia. More... |
| |
German Pharmaceutical Market Set to Hit $65 Billion by 2020
Germany is a mature market with high healthcare expenditure and pharmaceutical production but future growth could be potentially hindered by cost-saving government policies. More... |
| |
| Industry News |
The White House Responds to Superbug Threats
The White House confirmed that it would commit $1.2 billion to tackle the growing problem of antibiotic-resistant superbugs. More... |
| |
BMS Acquires Autoimmune Portfolio from Novo Nordisk
Bristol-Myers Squibb acquired an exclusive license for Novo Nordisk's discovery biologics research program. More... |
| |
Access to New Medicines Requires Transparency and Collaboration, Says WHO Report
The WHO report outlines possible policies that may help governments reduce the high prices of new medicines. More... |
| |
International Transport for Biologic Substances Expands
UPS expands its special commodities program to more countries. More... |
| |
Kemwell's Bangalore Facility Completes Successful FDA Inspection
FDA has concluded that Kemwell's facility, systems, and practices comply with FDA's requirements and no observations were reported on Form 483. More... |
| |
Novartis' Cosentyx Shows Promise in the Treatment of Psoriasis
Clinical trial results suggest that monoclonal antibodies targeting the function of proinflammatory cytokine IL-17A in psoriasis may be significantly superior to other treatments. More... |
| |
Biogen Idec Drops the Idec
The company's new corporate name will simply be Biogen. More... |
| |
